Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

Medical device giant Medtronic was hit with three lawsuits in the District of Delaware on Nov. 12—two by the previous ...

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...

Hexagon Health and its founder Dr. Shirin Towfigh diled a lawsuit in Delaware today against Medtronic (MDT), alleging Medtronic infringed three of Hexagon’s patents related to hernia mesh treatment ...

While companies haven’t disclosed the exact terms of the settlements, Medtronic has begun educating physicians about the shortcomings of its devices and providing QR codes on its devices that ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Fortunately for Medtronic, they have dozens of prospects outside of their insulin pumps and a considerable moat in cardiac devices. Make no mistake about it, while Medtronic is a solid company ...

Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...

However, to ensure uninterrupted inhibition of therapy, care must be exercised to maintain proper magnet positioning over the implanted device. St. Jude Medical and Medtronic were also asked about ...